Designed to Reduce System-Wide Healthcare Costs
An important by-product of increasing transplant volume and improving patient outcomes is a reduction in the system-wide burden of treating end-stage lung failure patients.
- Reduce cost of pre-transplant care: Increasing transplant volume shortens the time end-stage lung failure patients wait for a transplant, a period when medical care is very expensive.
- Reduce cost of post-transplant care: Improving outcomes by reducing the frequency of serious complications and shortening the average length of stay reduces the cost of post-surgical care.
The patient, hospital, and payers all benefit under these circumstances.